An advisory committee to the Food and Drug Administration (FDA) was told that unreasonable FDA restrictions on healthcare use of safe and effective antibacterial ingredients could jeopardize the safety of patients and healthcare workers alike. In a presentation to FDA’s Nonprescription Drugs Advisory Committee (NDAC) organized by the American Cleaning Institute (ACI), health professionals and industry safety experts said that active ingredients used in antibacterial hygiene products “clearly save lives” and are recognized as the “standard of care” for reducing healthcare infections.
“A robust body of research supports the safety of active ingredients used in healthcare antiseptic products,” wrote ACI in comments submitted to the NDAC panel. “Any suggestion that the benefit or risk of these products is in question, especially by FDA, could lead to unintended adverse consequences if usage patterns were to change in the healthcare setting.”
FDA is slated to propose a new set of rules governing antibacterial healthcare hygiene products in 2015.
Previous public announcements made by FDA – questioning the safety and efficacy of key antibacterial ingredients – have failed to acknowledge the full database of studies and research supporting the ingredients’ benefits and safety profiles.
“Healthcare providers need to have a full range of antibacterial actives at their disposal to best meet their infection control needs,” says Dr. Paul DeLeo, ACI associate vice president of environmental safety. “Any effort by FDA that would impede availability of these important ingredients would put patients and healthcare personnel at risk.”
Speakers at the ACI-organized presentation urged the Advisory Committee to recommend that FDA conduct a full risk assessment of currently available health and safety data on antibacterial ingredients.
“The active ingredients used in healthcare antiseptic drug products have a very favorable benefit/risk ratio demonstrated over many years of extensive use,” says Dr DeLeo. “These products clearly save lives by reducing bacterial transmission, which can cause infections in healthcare settings. By reducing healthcare-associated infections, these products also reduce healthcare costs.”
Source: American Cleaning Institute (ACI)
The Guardians of Animal Health: Who Are Veterinary Infection Preventionists?
March 21st 2025Veterinary infection control experts Leslie Kollmann, BS, AAS, CVT, CIC, Denise Waiting, LVT, and Leslie Landis, LVT, BS, discuss challenges, zoonotic disease risks, and the importance of education, collaboration, and resource development in animal care facilities.
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Resilience and Innovation: The Pivotal Contributions of Black Americans to Health Care and Medicine
February 24th 2025During Black History Month, we honor the resilience and contributions of Black medical professionals in health care. Despite barriers, they have led transformative changes, advocating for equitable access and medical excellence. Recognizing their impact ensures a more inclusive health care future for all.
Glove Usage Guideline: From The Joint Commission, CDC, and World Health Organization
February 17th 2025Proper glove use is crucial in health care settings to prevent infections. Guidelines from TJC, CDC, and WHO stress correct selection, usage, and disposal to minimize health care–associated infections (HAIs) and cross-contamination risks. Infection preventionists (IPs) play a key role in educating staff, enforcing compliance, and improving patient safety through standardized glove practices.